UIM6:XETRA:XETRA-UBS ETF SICAV - MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 507.06

Change

-5.10 (-1.00)%

Market Cap

USD 0.47B

Volume

119.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.11 (-0.21%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.04 (-0.23%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.15 (-0.55%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.04 (-0.13%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.09%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-0.38 (-0.27%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.07 (-0.13%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.81 (-0.83%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-5.36 (-0.95%)

USD 80.38B

ETFs Containing UIM6:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.04% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.04% 88% B+ 86% B+
Trailing 12 Months  
Capital Gain 29.74% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.74% 85% B 84% B
Trailing 5 Years  
Capital Gain 90.06% 95% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 90.06% 95% A 92% A
Average Annual (5 Year Horizon)  
Capital Gain 15.21% 86% B+ 83% B
Dividend Return 15.38% 86% B+ 82% B
Total Return 0.17% 14% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 15.06% 36% F 48% F
Risk Adjusted Return 102.11% 95% A 95% A
Market Capitalization 0.47B 64% D 56% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.